glucagon has been researched along with Hyperplasia in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (46.25) | 18.7374 |
1990's | 6 (7.50) | 18.2507 |
2000's | 16 (20.00) | 29.6817 |
2010's | 14 (17.50) | 24.3611 |
2020's | 7 (8.75) | 2.80 |
Authors | Studies |
---|---|
Casanueva-Álvarez, E; Cózar-Castellano, I; Fernández-Díaz, CM; González-Casimiro, CM; Kaestner, KH; Leissring, MA; Merino, B; Perdomo, G; Postigo-Casado, T; Quesada, I | 1 |
Cui, X; Gu, L; Hong, T; Lin, X; Wei, R; Yang, J; Yang, K | 1 |
Bai, X; Chen, X; Jia, J; Kang, Q; Li, M; Wong, FS; Xu, Y; Zhang, C; Zhang, XK; Zheng, J | 1 |
Bai, X; Han, D; Jia, J; Kang, Q; Li, M; Li, Z; Wu, X; Yuan, H | 1 |
Coulter-Parkhill, A; Dubey, V; Flatt, PR; Irwin, N; Lafferty, R; Moffett, C; O'Harte, F; Tanday, N; Vishal, K | 1 |
Klöppel, G; Sipos, B | 1 |
de Herder, WW; Klöppel, G | 1 |
Anguiano, G; Cavino, K; Chen, S; Gromada, J; Hamid, R; Huang, Z; Kim, J; Lee, J; Li, WH; Liu, Q; Murphy, AJ; Na, E; Okamoto, H; Unger, R; Xin, Y; Xu, Y; Yancopoulos, GD; Zambrowicz, B | 1 |
Clifton-Bligh, RJ; Gild, ML; Gill, AJ; Samra, J; Tacon, L; Tsang, V | 1 |
Gilbert, RE; Jin, T; Thai, K; Woo, M; Zhang, Y | 1 |
Cavino, K; Dominguez Gutierrez, G; Gromada, J; Kim, J; Kloeppel, G; Okamoto, H; Sipos, B; Sung, B; Xin, Y | 1 |
Hayashi, Y; Itoh, M; Murata, Y; Takagishi, Y; Xu, S | 1 |
Betts, CJ; Bickerton, S; Bigley, AL; Brocklehurst, SR; Jenkins, RP; Jones, HB; Morgan, D; Reens, J; Smith, DM; Whalley, NM | 1 |
Bang, S; Choi, H; Kang, CM; Kang, H; Kim, HG; Kim, S; Lee, HW; Lim, TS | 1 |
Barrande, G; Bertherat, J; Desailloud, R; Duparc, C; Gobet, F; Groussin, L; Lefebvre, H; Louiset, E; Prévost, G; Reznik, Y | 1 |
Anlauf, M; Boehm, BO; Buch, S; Couvelard, A; Hammel, P; Hampe, J; Henopp, T; Höbling, W; Hoffmeister, M; Klöppel, G; Lieb, W; Sipos, B; Sperveslage, J; Weber, A | 1 |
Cavino, K; Gromada, J; Harp, J; Kim, S; Krumm, E; Murphy, AJ; Na, E; Okamoto, H; Stevis, PE; Yancopoulos, GD | 1 |
Chen, CR; Dhall, D; Nissen, NN; Yu, R; Zhou, C | 1 |
Atangan, L; Bi, V; Boone, T; Gu, W; Hill, D; Hu, S; Komorowski, R; Lindberg, RA; Shen, Y; Sivits, G; Véniant, MM; Vonderfecht, S; Winters, KA; Yan, H; Yang, J | 1 |
Hayashi, Y; Ito, R; Mizoguchi, H; Murata, Y; Sun, XY; Watanabe, C; Yamamoto, M; Yamamoto, S | 1 |
Chintinne, M; Declercq, J; Di Pietro, C; Ectors, N; Gysemans, C; Heimberg, H; Kumar, A; Lemaire, K; Mathieu, C; Pipeleers, D; Schraenen, A; Schuit, FC; Van De Casteele, M; Van de Ven, WJ; Van Lommel, L; Verfaillie, CM | 1 |
Alison, MR; El-Bahrawy, ME; Fritsch, K; Guppy, NJ; Jeffery, RE; Kocher, HM; Otto, WR; Poulsom, R; Qureshi, YA; Wright, NA | 1 |
Ali, S; Charron, MJ; Dai, C; de Chavez, V; Dean, ED; Drucker, DJ; Longuet, C; McGuinness, I; Powers, AC; Robledo, AM; Vuguin, PM | 1 |
Habener, JF; Stanojevic, V | 1 |
Schiel, KA | 1 |
Charron, MJ; Cui, L; Dichmann, DS; Du, XQ; Fledelius, C; Gelling, RW; Holst, JJ; Huang, H; Jelicks, LA; Johansen, PB; Nishimura, E; Obici, S; Romer, J; Rossetti, L; Serup, P; Tang, B | 1 |
Büchler, MW; Friess, H; Kated, H; Martignoni, ME; Nitzsche, EU; Schirp, U; Stiegler, M; Zimmermann, A | 1 |
Cummings, DE | 1 |
Charron, MJ; Cui, L; Gelling, RW; Guz, Y; Kedees, MH; Nejathaim, M; Teitelman, G; Vuguin, PM | 1 |
Alison, MR; Sarraf, CE; Shen, CN; Slack, JM; Tosh, D | 1 |
Függer, R; Funovics, J; Schulz, F; Ulrich, W; Zöch, G | 1 |
Doull, V; Friesen, S; Tomita, T; Visser, P | 1 |
Allo, MD; Eckhauser, FE; Lloyd, RV; Mervak, T; Nishiyama, RH; Strodel, WE; Talpos, G; Thompson, NW; Vinik, AI | 1 |
Fujita, T; Hirata, Y; Kakita, T; Matsukura, S; Sueoka, S; Yokota, M; Yoshimi, H | 1 |
Mahler, RJ | 2 |
von Dorsche, HH; Ziegler, M | 1 |
Brennan, MD; Carpenter, AM; Edis, AJ; Rubenstein, AH; Service, FJ | 1 |
Atkins, TW; Bailey, CJ; Flatt, PR | 1 |
Bloom, SR; Fuller, CR; Ghatei, MA; Hoyt, EC; Lund, PK; Ulshen, MH | 1 |
Contis, J; Kaminski, DL; Li, AP; Solomon, H | 1 |
Bellini, F; Ianni, L; Lanzillotti, R; Mannelli, M; Natali, A; Pupilli, C | 1 |
Bosch, F; Casellas, A; Devedjian, JC; George, M; Gros, L; Pelegrín, M; Pujol, A; Visa, J | 1 |
Ashok, S; Deepa, R; Govindarajan, M; Mohan, V; Pitchumoni, CS | 1 |
Bucchini, D; Cordonnier, N; Desbois, P; Duvillié, B; Jackerott, M; Jami, J; Joshi, RL; Lamotte, L; Leroux, L | 1 |
Cincotta, AH; Jetton, TL; Liang, Y | 1 |
Allen, MR; Andrews, KM; McNeish, JD; Parker, JC; Stock, JL | 1 |
Akbar, MS; Steiner, DF; Swift, HH; Webb, GC; Zhao, C | 1 |
Bucchini, D; Chrones, T; Currie, C; Duvillié, B; Hill, DJ; Jami, J; Joshi, RL | 1 |
Ammann, R; Hedinger, C; Säuberli, H; Woodtli, W; Zimmermann, K | 1 |
Welbourn, RB | 1 |
Amherdt, M; Baetens, D; Malaisse-Lagae, F; Orci, L; Ravazzola, M; Rufener, C; Studer, P; Unger, RH | 1 |
Larsson, LI | 1 |
Bommer, G; Commandeur, G; Heitz, P; Klöppel, G | 1 |
Thomas, M; Vigouroux, N | 1 |
Benichou, J; Francavilla, A; Jones, AF; Porter, KA; Starzl, TE | 1 |
Andreani, D; Natoli, C; Tamburrano, G; Tamburrano, S | 1 |
Schwartz, TW | 1 |
Accary, JP; Mignon, M; Soulé, JC | 1 |
Chertow, BS; Fariss, BL; Schikman, CH | 1 |
Aurbach, GD; Brown, EM; Marx, SJ; Spiegel, AM | 1 |
Farouk, M; McVey, DC; Meyers, WC; Vigna, SR | 1 |
Arai, T; Oki, Y; Sasaki, M; Usui, T | 1 |
Hisaoka, M; Horie, A | 1 |
Goudswaard, WB; Houthoff, HJ; Koudstaal, J; Zwierstra, RP | 1 |
Andreu, M; Greaves, P; Spencer, AJ | 1 |
Grizzle, WE; Herrera, GA; Kheir, SM; Lee, I; Omura, EF | 1 |
Ambrosius, H; Fuchs, U; von Dorsche, HH; Ziegler, M | 1 |
Domingo, J; Estadella, MD; Pujol, MJ | 1 |
Fujinaka, S; Hamajo, T; Kobashi, K; Onoe, K; Yamamoto, T | 1 |
Chayoth, R; Epstein, SM; Field, JB | 1 |
Croisier, JC; Lehy, T; Zeitoun, P | 1 |
Hunter, DJ; Isles, TE | 1 |
Forsham, PH; Grodsky, GM; Karam, JH | 1 |
Barnes, GL | 1 |
Misugi, K; Misugi, N; Smith, B; Sotos, J | 1 |
Max, MH; Price, JB; Takeshige, K; Voorhees, AB | 1 |
Cummings, D; Harper, PV; Lawrence, AM; Paloyan, D; Paloyan, E; Straus, FH | 1 |
Chivu, V; Lupulescu, A; Petrovici, A | 1 |
Horita, M; Ishimatsu, T; Iwashita, K; Kodama, M; Ono, J; Oribe, Y; Sato, Y; Shigematsu, S; Shimoyama, N; Takaki, R | 1 |
10 review(s) available for glucagon and Hyperplasia
Article | Year |
---|---|
Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease.
Topics: Animals; Glucagon; Glucagon-Secreting Cells; Humans; Hyperplasia; Mice; Neoplasms; Receptors, Glucagon | 2023 |
One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones.
Topics: Animals; Dogs; Glucagon; Hyperplasia; Insulin; Insulinoma; Pancreatic Neoplasms | 2023 |
Alpha cells come of age.
Topics: Animals; Cell Dedifferentiation; Cell Lineage; Cell Transdifferentiation; Diabetes Mellitus, Experimental; Enteroendocrine Cells; Epithelial-Mesenchymal Transition; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Homeodomain Proteins; Humans; Hyperplasia; Insulin-Secreting Cells; Islets of Langerhans; Mice; Paired Box Transcription Factors; Proprotein Convertase 1; Signal Transduction; Transcription Factors | 2013 |
The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity.
Topics: Adipose Tissue; Alloxan; Animals; Glucagon; Glucose; Humans; Hyperplasia; Insulin; Insulin Resistance; Islets of Langerhans; Liver; Mice; Mice, Obese; Microscopy, Electron; Muscles; Obesity; Receptor, Insulin; Streptozocin | 1981 |
Apudomas of the gut.
Topics: Acute Kidney Injury; Adenoma, Islet Cell; Adult; Amines; Carboxy-Lyases; Dehydration; Endocrine Glands; Fluorescent Antibody Technique; Gastrins; Glucagon; Humans; Hyperplasia; Intestinal Neoplasms; Intestinal Secretions; Intestines; Male; Multiple Endocrine Neoplasia; Neurosecretory Systems; Pancreas; Paraneoplastic Endocrine Syndromes; Peptides; Zollinger-Ellison Syndrome | 1977 |
[Hormones of the digestive system. II. Pathology].
Topics: Acute Kidney Injury; Adenoma, Islet Cell; Adolescent; Adult; Aged; Carcinoid Tumor; Child; Dehydration; Female; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Gastrointestinal Neoplasms; Glucagon; Humans; Hyperplasia; Hypokalemia; Insulin; Insulin Secretion; Male; Middle Aged; Pancreatic Neoplasms; Paraneoplastic Endocrine Syndromes; Precancerous Conditions; Serotonin; Somatostatin; Syndrome; Vasoactive Intestinal Peptide; Zollinger-Ellison Syndrome | 1978 |
[Pathophysiological significance of hypergastrinaemia in man (author's transl)].
Topics: Anemia, Pernicious; Calcium; Dietary Proteins; Duodenal Ulcer; Gastric Juice; Gastrins; Gastritis; Glucagon; Humans; Hyperplasia; Intestine, Small; Kidney Failure, Chronic; Pyloric Antrum; Pyloric Stenosis; Secretin; Stomach Neoplasms; Stomach Ulcer; Vagotomy; Zollinger-Ellison Syndrome | 1977 |
[Hypoglycemia and its countermeasures].
Topics: Acute Disease; Adenoma, Islet Cell; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Animals; Blood Glucose; Cortisone; Diazoxide; Ethanol; Female; Gastrectomy; Glucagon; Growth Hormone; Humans; Hyperplasia; Hypoglycemia; Hypoglycemic Agents; Hypophysectomy; Hypothyroidism; Insulin; Insulin Secretion; Liver Diseases; Male; Middle Aged; Osteosarcoma; Rats; Xylitol | 1969 |
The pathogenesis of pancreatic islet cell hyperplasia and insulin insensitivity in obesity.
Topics: Adrenal Cortex; Amino Acids; Biological Transport, Active; Epinephrine; Fatty Acids, Nonesterified; Genes; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Hyperplasia; Hypothalamus; Insulin; Islets of Langerhans; Obesity | 1974 |
Insulin secretion in obesity: pseudodiabetes?
Topics: Age Factors; Animals; Diabetes Mellitus; Glucagon; Glucose; Humans; Hyperplasia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans | 1968 |
70 other study(ies) available for glucagon and Hyperplasia
Article | Year |
---|---|
Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.
Topics: alpha-Synuclein; Animals; Cell Proliferation; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Secreting Cells; Hyperplasia; Insulin; Insulin-Secreting Cells; Insulysin; Mice | 2022 |
γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; gamma-Aminobutyric Acid; Glucagon; Hyperplasia; Insulin; Insulin-Secreting Cells; Mice; Receptors, Glucagon; Regeneration | 2023 |
Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish.
Topics: Animals; Glucagon; Hyperplasia; Receptors, Glucagon; RNA, Messenger; Zebrafish | 2022 |
Crispr-Cas9 mediated complete deletion of glucagon receptor in mice display hyperglucagonemia and α-cell hyperplasia.
Topics: Animals; CRISPR-Cas Systems; Glucagon; Hyperplasia; Mice; Mice, Knockout; Receptors, Glucagon | 2023 |
The glucagon receptor antagonist desHis
Topics: Animals; Blood Glucose; Glucagon; Humans; Hyperplasia; Insulin; Mice; Receptors, Glucagon | 2023 |
Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.
Topics: Amino Acid Transport Systems, Neutral; Animals; Glucagon; Glucagon-Secreting Cells; Hyperplasia; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Receptors, Glucagon; Signal Transduction | 2017 |
Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association.
Topics: Carcinoma, Neuroendocrine; Glucagon; Glucagon-Secreting Cells; Humans; Hypercalcemia; Hyperplasia; Lymphatic Metastasis; Male; Middle Aged; Mutation, Missense; Pancreatic Neoplasms; Paraneoplastic Syndromes; Receptors, Glucagon; Syndrome | 2018 |
SIRT1 activation attenuates α cell hyperplasia, hyperglucagonaemia and hyperglycaemia in STZ-diabetic mice.
Topics: Anilides; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Hyperglycemia; Hyperplasia; Insulin; Male; Mice; Sirtuin 1; Thiazoles | 2018 |
Increased SLC38A4 Amino Acid Transporter Expression in Human Pancreatic α-Cells After Glucagon Receptor Inhibition.
Topics: Adult; Amino Acid Transport System A; Animals; Cell Proliferation; Female; Glucagon; Glucagon-Secreting Cells; Humans; Hyperplasia; Islets of Langerhans Transplantation; Male; Mice; Middle Aged; Receptors, Glucagon; Signal Transduction; Transplantation, Heterologous | 2019 |
Aristaless-related homeobox plays a key role in hyperplasia of the pancreas islet α-like cells in mice deficient in proglucagon-derived peptides.
Topics: Animals; Blood Glucose; Body Weight; Female; Gene Expression; Glucagon; Green Fluorescent Proteins; Homeodomain Proteins; Hyperplasia; Immunohistochemistry; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; Mutation; Peptides; Proglucagon; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors | 2013 |
Islets of Langerhans from prohormone convertase-2 knockout mice show α-cell hyperplasia and tumorigenesis with elevated α-cell neogenesis.
Topics: Adenoma; Animals; Carcinogenesis; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Glucagon; Glucagon-Secreting Cells; Hyperplasia; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pancreatic Neoplasms; Proprotein Convertase 2 | 2014 |
[A case of alpha-cell nesidioblastosis and hyperplasia with multiple glucagon-producing endocrine cell tumor of the pancreas].
Topics: Adult; Chromogranin A; Female; Glucagon; Glucagon-Secreting Cells; Humans; Hyperplasia; Islets of Langerhans; Nesidioblastosis; Neuroendocrine Tumors; Pancreas; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Abnormal Sensitivity to Glucagon and Related Peptides in Primary Adrenal Cushing's Syndrome.
Topics: Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Cushing Syndrome; Female; Glucagon; Humans; Hydrocortisone; Hyperplasia; Immunohistochemistry; Kinetics; Male; Middle Aged; Peptides; Receptors, Glucagon; Young Adult | 2014 |
Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations.
Topics: Adult; Aged; Female; Glucagon; Glucagon-Secreting Cells; Humans; Hyperplasia; Male; Middle Aged; Mutation; Pancreas; Pancreatic Neoplasms; Receptors, Glucagon | 2015 |
Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.
Topics: Angiopoietin-Like Protein 4; Animals; Blood Glucose; Cell Proliferation; Glucagon; Glucagon-Secreting Cells; Humans; Hyperplasia; Lipid Metabolism; Lipoproteins; Liver; Mice; Mice, Knockout; Receptors, Glucagon; Signal Transduction; Triglycerides | 2017 |
Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
Topics: Aged; Amino Acid Sequence; Base Sequence; Carcinoma, Islet Cell; Cell Line; Cell Membrane; DNA Mutational Analysis; Female; Fluorescent Antibody Technique; Glucagon; Glucagon-Secreting Cells; Green Fluorescent Proteins; Homozygote; Humans; Hyperplasia; Immunoblotting; Male; Molecular Sequence Data; Mutation, Missense; Pancreatic Neoplasms; Pedigree; Receptors, Glucagon; Transfection | 2009 |
Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Topics: Animals; Antibodies, Monoclonal; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Glucagon-Secreting Cells; Glucose; Hyperglycemia; Hyperplasia; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Obesity; Receptors, Glucagon; Tachyphylaxis | 2009 |
Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells.
Topics: Animals; Enteroendocrine Cells; Flow Cytometry; Gene Knock-In Techniques; Genotype; Glucagon; Glucagon-Secreting Cells; Hyperplasia; Immunoenzyme Techniques; Immunohistochemistry; Islets of Langerhans; Mice | 2009 |
Pdx1- and Ngn3-Cre-mediated PLAG1 expression in the pancreas leads to endocrine hormone imbalances that affect glucose metabolism.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Proliferation; DNA-Binding Proteins; Glucagon; Glucose; Glucose Tolerance Test; Homeodomain Proteins; Homeostasis; Hyperplasia; Hypoglycemia; Insulin; Integrases; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Transgenic; Nerve Tissue Proteins; Organ Size; Pancreatic Hormones; Somatostatin; Time Factors; Trans-Activators | 2011 |
Trefoil factor family peptides in normal and diseased human pancreas.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation; Glucagon; Humans; Hyperplasia; Immunohistochemistry; In Situ Hybridization; Insulin; Ki-67 Antigen; Mucin 5AC; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Peptides; RNA, Messenger; Trefoil Factor-2; Trefoil Factor-3 | 2012 |
Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Topics: Animals; Blood Glucose; Female; Glucagon; Glucagon-Secreting Cells; Glucose; Hepatocytes; Hyperplasia; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Islets of Langerhans; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Glucagon; Signal Transduction | 2013 |
An etiologic model proposing that non-insulin-dependent diabetes mellitus is chronic hypoxic stress hyperglycemia.
Topics: Anemia; Arteriosclerosis; Arthritis, Rheumatoid; Blood Glucose; Brain; Catecholamines; Diabetes Mellitus, Type 2; Edema; Endothelins; Endothelium, Vascular; Ephedrine; Glucagon; Hemorheology; Hydrocortisone; Hyperglycemia; Hyperplasia; Hypothalamo-Hypophyseal System; Hypoxia; Mitosis; Models, Biological; Muscle, Smooth, Vascular; Pituitary-Adrenal System; Sympathetic Nervous System; Vasodilation | 2002 |
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
Topics: Animals; Blood Glucose; Body Weight; Calorimetry; Cell Division; Cyclic AMP; Epididymis; Epinephrine; Glucagon; Glucose; Hormones; Hyperplasia; Immunohistochemistry; Insulin; Islets of Langerhans; Liver; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Phenotype; Receptors, Glucagon; Time Factors | 2003 |
Nesidioblastosis with glucagon-reactive islet cell hyperplasia: a case report.
Topics: Glucagon; Humans; Hyperplasia; Immunohistochemistry; Insulin; Islets of Langerhans; Male; Middle Aged; Pancreatic Diseases | 2003 |
Gastric bypass and nesidioblastosis--too much of a good thing for islets?
Topics: Adenosine Deaminase Inhibitors; Dipeptidyl Peptidase 4; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glycoproteins; Humans; Hyperinsulinism; Hyperplasia; Hypoglycemia; Islets of Langerhans; Nesidioblastosis; Obesity; Peptide Fragments; Postoperative Complications; Protein Precursors; Signal Transduction | 2005 |
Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation.
Topics: Animals; Blood Glucose; Cell Differentiation; Cell Division; Feedback, Physiological; Female; Fetal Death; Fetal Development; Gene Deletion; Genotype; Glucagon; Hyperplasia; Insulin; Islets of Langerhans; Male; Mice; Mice, Knockout; Microscopy, Confocal; Pregnancy; Receptors, Glucagon; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2006 |
Copper deprivation in rats induces islet hyperplasia and hepatic metaplasia in the pancreas.
Topics: Animals; Copper; Glucagon; Glycogen; Hepatocytes; Hyperplasia; Insulin; Islets of Langerhans; Liver; Male; Metaplasia; Rats; Rats, Wistar | 2007 |
[Tumors of the endocrine pancreas].
Topics: Adenoma, Islet Cell; Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Gastrectomy; Gastrins; Glucagon; Humans; Hyperplasia; Insulin; Insulinoma; Islets of Langerhans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Postoperative Complications; Stomach Neoplasms; Zollinger-Ellison Syndrome | 1984 |
Cortisone-induced islet cell hyperplasia in hamsters.
Topics: Animals; Blood Glucose; Cortisone; Cricetinae; Female; Glucagon; Hyperplasia; Insulin; Islets of Langerhans; Mesocricetus; Pancreas; Pancreatic Polypeptide; Somatostatin; Time Factors | 1984 |
MEN I pancreas: a histological and immunohistochemical study.
Topics: Adenoma, Islet Cell; Adult; Female; Gastrins; Glucagon; Humans; Hyperplasia; Islets of Langerhans; Male; Middle Aged; Multiple Endocrine Neoplasia; Pancreatic Neoplasms; Pancreatic Polypeptide; Phosphopyruvate Hydratase; Serotonin; Somatostatin; Staining and Labeling; Vasoactive Intestinal Peptide; Zollinger-Ellison Syndrome | 1984 |
Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors.
Topics: Adenoma; Adenylyl Cyclases; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Cushing Syndrome; Cyclic AMP; Glucagon; Humans; Hyperplasia; Prostaglandins E; Receptors, Cell Surface | 1980 |
[A-cell-hyperplasia of islets of Langerhans on rabbits after immunisation with glucagon (author's transl)].
Topics: Animals; Antibody Formation; Fluorescent Antibody Technique; Glucagon; Hyperplasia; Islets of Langerhans; Rabbits | 1981 |
Diagnosis of pancreatic islet hyperplasia causing hypoglycemia in a patient with portacaval anastomosis.
Topics: Blood Chemical Analysis; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperplasia; Hypoglycemia; Insulin; Islets of Langerhans; Middle Aged; Portacaval Shunt, Surgical; Tolbutamide | 1980 |
Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice.
Topics: Aging; Animals; Female; Glucagon; Hyperglycemia; Hyperplasia; Insulin; Islets of Langerhans; Male; Mice; Mice, Obese | 1982 |
Increased ileal proglucagon expression after jejunectomy is not suppressed by inhibition of bowel growth.
Topics: Adaptation, Physiological; Animals; Blotting, Northern; Eflornithine; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Hyperplasia; Ileum; Intestinal Mucosa; Jejunum; Male; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Peptide Fragments; Proglucagon; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1996 |
The effect of prostanoids on hepatic bile flow in dogs with normal liver and bile duct cell hyperplasia.
Topics: 1-Naphthylisothiocyanate; Animals; Bile; Bile Acids and Salts; Bile Duct Diseases; Cholestasis; Common Bile Duct; Dinoprostone; Dogs; Epoprostenol; Glucagon; Hyperplasia; Secretin | 1996 |
Glucocorticoid-phenylethanolamine-N-methyltransferase interactions in humans.
Topics: Adenoma; Adrenal Cortex Diseases; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Epinephrine; Female; Glucagon; Humans; Hydrocortisone; Hyperplasia; Male; Norepinephrine; Phenylethanolamine N-Methyltransferase | 1998 |
Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Fats; Fatty Liver; Gene Expression; Glucagon; Glucose; Glucose Tolerance Test; Hyperinsulinism; Hyperplasia; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; RNA, Messenger | 2000 |
Histopathology and immunohistochemistry of pancreatic islets in fibrocalculous pancreatic diabetes.
Topics: Adolescent; Adult; Atrophy; Biopsy; Blood Glucose; Chronic Disease; Diabetes Mellitus; Female; Gastrins; Glucagon; Humans; Hyperplasia; Immunohistochemistry; Insulin; Islets of Langerhans; Male; Middle Aged; Pancreas; Pancreatic Ducts; Pancreatic Polypeptide; Pancreatitis; Vasoactive Intestinal Peptide | 2001 |
Compensatory responses in mice carrying a null mutation for Ins1 or Ins2.
Topics: Animals; Blotting, Western; Cell Count; Female; Gene Expression; Glucagon; Hyperplasia; Immunohistochemistry; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Mutation; Pancreatic Polypeptide; Proinsulin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Somatostatin | 2001 |
Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Topics: Animals; Apoptosis; Cell Division; DNA; Dopamine Agonists; Female; Glucagon; Glucokinase; Glucose Transporter Type 2; Hyperplasia; Immunohistochemistry; In Situ Nick-End Labeling; Insulin; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Obese; Monosaccharide Transport Proteins; Somatostatin; Sympatholytics | 2001 |
Glycemic control in mice with targeted disruption of the glucagon receptor gene.
Topics: Animals; Blood Glucose; Cholesterol; Gene Targeting; Glucagon; Glucose; Glucose Tolerance Test; Hyperplasia; Insulin; Metabolism, Inborn Errors; Mice; Mice, Knockout; Organ Size; Pancreas; Phenotype; Receptors, Glucagon; Triglycerides | 2002 |
Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in prohormone convertase 2 knockout mice.
Topics: Animals; Apoptosis; Blood Glucose; Gene Expression; Glucagon; Hyperplasia; Hypoglycemia; Islets of Langerhans; Liver; Mice; Mice, Knockout; Proprotein Convertase 2; Subtilisins | 2002 |
Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.
Topics: Animals; Apoptosis; Body Weight; Cell Division; Embryonic and Fetal Development; Endothelial Growth Factors; Glucagon; Hyperplasia; Immunohistochemistry; Insulin; Insulin-Like Growth Factor II; Islets of Langerhans; Lymphokines; Mice; Mice, Knockout; Neovascularization, Physiologic; Proliferating Cell Nuclear Antigen; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
[Glucagon producing adenomatosis of Islands of Langerhans with polyendocrine symptoms].
Topics: Adipose Tissue; Adrenal Cortex; Adrenal Glands; Adult; Calcinosis; Cholecystectomy; Cushing Syndrome; Diabetes Complications; Gastrins; Glucagon; Humans; Hyperplasia; Islets of Langerhans; Male; Multiple Endocrine Neoplasia; Necrosis; Obesity; Pancreas; Zollinger-Ellison Syndrome | 1976 |
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes.
Topics: Adult; Animals; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Hyperplasia; Hypertrophy; Insulin; Islets of Langerhans; Male; Rats; Somatostatin; Streptozocin | 1976 |
Two distinct types of islet abnormalities associated with endocrine pancreatic tumours.
Topics: Gastrins; Glucagon; Growth Hormone-Releasing Hormone; Humans; Hyperplasia; Insulin; Islets of Langerhans; Pancreatic Neoplasms; Peptides | 1977 |
The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies.
Topics: Adult; Aged; Chronic Disease; Female; Glucagon; Humans; Hyperplasia; Insulin; Islets of Langerhans; Male; Microscopy, Electron; Middle Aged; Pancreas; Pancreatitis; Somatostatin | 1978 |
Liver regeneration in dogs: morphologic and chemical changes.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Dogs; Glucagon; Hepatectomy; Hyperplasia; Hypertrophy; Insulin; Liver; Liver Regeneration | 1978 |
[The insulinomas].
Topics: Adenoma, Islet Cell; Diazoxide; Glucagon; Humans; Hyperplasia; Insulin; Insulin Secretion; Pancreatic Diseases; Pancreatic Neoplasms; Tolbutamide | 1979 |
Pancreatic-polypeptide (PP) and endocrine tumours of the pancreas.
Topics: Acute Kidney Injury; Adenoma, Islet Cell; Dehydration; Gastrins; Glucagon; Humans; Hyperplasia; Molecular Weight; Pancreas; Pancreatic Neoplasms; Pancreatic Polypeptide; Syndrome; Zollinger-Ellison Syndrome | 1979 |
Paradoxical enhancement of tolbutamide-induced insulin release by diazoxide in a patient with islet cell hyperplasia.
Topics: Blood Glucose; Child; Diazoxide; Glucagon; Glucose Tolerance Test; Humans; Hyperplasia; Hypoglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreatic Diseases; Propranolol; Tolbutamide | 1978 |
Family studies in patients with primary parathyroid hyperplasia.
Topics: Adolescent; Adult; Aged; Calcium; Child; Female; Gastrins; Glucagon; Humans; Hypercalcemia; Hyperplasia; Male; Middle Aged; Neoplasms, Multiple Primary; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Pedigree; Prolactin | 1977 |
Localization and characterization of secretin binding sites expressed by rat bile duct epithelium.
Topics: Animals; Autoradiography; Bile Ducts; Binding Sites; Binding, Competitive; Cholecystokinin; Dose-Response Relationship, Drug; Epithelium; Gastric Inhibitory Polypeptide; Glucagon; Growth Hormone-Releasing Hormone; Hyperplasia; Liver; Male; Rats; Rats, Inbred Strains; Receptors, G-Protein-Coupled; Receptors, Gastrointestinal Hormone; Secretin; Vasoactive Intestinal Peptide | 1992 |
Immunohistochemical, ultrastructural, and hormonal studies on the endocrine pancreas of voles (Microtus arvalis) with monosodium aspartate-induced diabetes.
Topics: Animals; Arvicolinae; Aspartic Acid; Blood Glucose; Cytoplasmic Granules; Diabetes Mellitus, Experimental; Female; Glucagon; Hyperplasia; Hypertrophy; Immunohistochemistry; Insulin; Islets of Langerhans; Male; Microscopy, Electron; Rodent Diseases; Somatostatin | 1991 |
Unusual proliferation of the pancreatic endocrine cells in adults, suggestive of islet cell metaplasia.
Topics: Carcinoma, Squamous Cell; Cell Division; Glucagon; Humans; Hyperplasia; Immunohistochemistry; Insulin; Islets of Langerhans; Lung Neoplasms; Male; Metaplasia; Middle Aged; Multiple Myeloma; Pancreatic Polypeptide; Somatostatin | 1990 |
Nesidioblastosis and endocrine hyperplasia of the pancreas: a secondary phenomenon.
Topics: Adult; Aged; Child, Preschool; Glucagon; Humans; Hyperinsulinism; Hyperplasia; Infant; Infant, Newborn; Insulin; Insulinoma; Islets of Langerhans; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatin | 1986 |
Neoplasia and hyperplasia of pancreatic endocrine tissue in the rat: an immunocytochemical study.
Topics: Adenoma, Islet Cell; Animals; Female; Glucagon; Hyperplasia; Immunoassay; Insulin; Insulinoma; Islets of Langerhans; Male; Pancreatic Neoplasms; Rats; Rats, Inbred Strains; Species Specificity | 1986 |
Histologic variation in the skin lesions of the glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Female; Glucagon; Glucagonoma; Humans; Hyperplasia; Male; Middle Aged; Necrosis; Pancreas; Pancreatic Neoplasms; Skin; Skin Diseases; Syndrome | 1986 |
Anti-glucagon insulitis and A-cell hyperplasia of pancreatic islets.
Topics: Animals; Glucagon; Hyperplasia; Immunization, Passive; Inflammation; Insulin; Insulin Secretion; Islets of Langerhans; Mice | 1988 |
Proliferative response of putative preneoplastic hepatocytes to triiodothyronine, aminoacids, glucagon and heparine.
Topics: Amino Acids; Animals; Cell Division; Diethylnitrosamine; Glucagon; Heparin; Hyperplasia; Liver Neoplasms; Male; Phenobarbital; Precancerous Conditions; Rats; Rats, Inbred Strains; Triiodothyronine | 1988 |
Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats.
Topics: Adenylyl Cyclases; Animals; Carcinoma, Hepatocellular; Cyclic AMP; Ethionine; Glucagon; Hyperplasia; Liver; Liver Neoplasms; Male; Neoplasms, Experimental; Phosphoric Diester Hydrolases; Prostaglandins; Rats; Stimulation, Chemical | 1973 |
A2 cell pancreatic microadenomas in a case of multiple endocrine adenomatosis.
Topics: Adrenal Gland Diseases; Adult; Duodenal Ulcer; Female; Glucagon; Histocytochemistry; Humans; Hyperparathyroidism; Hyperplasia; Hypoglycemia; Microscopy, Electron; Multiple Endocrine Neoplasia; Parathyroid Neoplasms; Peptic Ulcer Perforation; Zollinger-Ellison Syndrome | 1971 |
The insulinogenic effect of glucagon in the newborn.
Topics: Blood Glucose; Female; Glucagon; Humans; Hyperplasia; Infant, Newborn; Insulin; Insulin Secretion; Islets of Langerhans; Pregnancy; Stimulation, Chemical | 1972 |
Persistent neonatal hypoglycaemia: a case report.
Topics: Female; Glucagon; Glucose; Humans; Hyperplasia; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Islets of Langerhans; Pancreatectomy; Prognosis | 1969 |
The pancreatic islet of infants with severe hypoglycemia.
Topics: Blood Glucose; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hyperplasia; Hypertrophy; Hypoglycemia; Infant; Infant, Newborn; Insulin; Islets of Langerhans; Leucine; Microscopy, Electron; Radioimmunoassay; Time Factors; Tolbutamide | 1970 |
Glucagon as the portal factor modifying hepatic regeneration.
Topics: Animals; Aspartate Aminotransferases; Autoradiography; DNA; Dogs; Female; Glucagon; Hepatectomy; Hyperplasia; Hypertrophy; Jugular Veins; Liver Circulation; Liver Glycogen; Liver Regeneration; Male; Organ Size; Pancreatectomy; Portacaval Shunt, Surgical; RNA; Thymidine | 1972 |
Alpha cell hyperplasia in calcific pancreatitis associated with hyperparathyroidism.
Topics: Adenoma; Aged; Calcium; Chronic Disease; Glucagon; Humans; Hyperparathyroidism; Hyperplasia; Islets of Langerhans; Male; Pancreatitis; Parathyroid Neoplasms | 1967 |
Effect of aldosterone, glucagon and growth hormone on the catechol amine content and the evolution of chromaffin hyperplasia in guinea pigs.
Topics: Adrenal Medulla; Aldosterone; Animals; Chromaffin System; Epinephrine; Estradiol; Glucagon; Growth Hormone; Guinea Pigs; Hyperplasia; Norepinephrine | 1966 |
[A case of multiple endocrine neoplasia, type 1, with parathyroid adenoma, multinodular adrenal cortical hyperplasia, islet cell tumor and hyperplasia of thyroid with concomitant hypersecretion of gastrin and total glucagon-like immunoreactivity].
Topics: Adenoma; Adenoma, Islet Cell; Adrenal Cortex; Female; Gastrins; Glucagon-Like Peptides; Humans; Hydrocortisone; Hyperplasia; Middle Aged; Multiple Endocrine Neoplasia; Pancreatic Neoplasms; Parathyroid Neoplasms; Peptides; Thyroid Gland; Thyroid Hormones | 1989 |